XML 39 R31.htm IDEA: XBRL DOCUMENT v2.4.1.9
Segment Information (Tables)
 9 Months Ended
Dec. 31, 2014
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Financial information relating to our reportable operating segments and reconciliations to the condensed consolidated totals is as follows:
 
Quarter Ended December 31,
 
Nine Months Ended December 31,
(In millions)
2014
 
2013
 
2014
 
2013
Revenues
 
 
 
 
 
 
 
Distribution Solutions (1)
 
 
 
 
 
 
 
North America pharmaceutical distribution and services
$
37,398

 
$
32,060

 
$
106,850

 
$
92,808

International pharmaceutical distribution and services
7,288

 
—

 
22,207

 
—

Medical-Surgical distribution & services
1,564

 
1,462

 
4,471

 
4,286

Total Distribution Solutions
46,250

 
33,522

 
133,528

 
97,094

 
 
 
 
 
 
 
 
Technology Solutions - products and services
755

 
814

 
2,293

 
2,466

Total Revenues
$
47,005

 
$
34,336

 
$
135,821

 
$
99,560

 
 
 
 
 
 
 
 
Operating profit
 
 
 
 
 
 
 
Distribution Solutions (2) (3) (4)
$
785

 
$
552

 
$
2,326

 
$
1,856

Technology Solutions (5) (6)
111

 
47

 
304

 
294

Total
896

 
599

 
2,630

 
2,150

Corporate Expenses, Net (7)
(103
)
 
(112
)
 
(317
)
 
(307
)
Interest Expense
(97
)
 
(69
)
 
(297
)
 
(187
)
Income from Continuing Operations Before Income Taxes
$
696

 
$
418

 
$
2,016

 
$
1,656

(1)
Revenues derived from services represent less than 2% of this segment’s total revenues.
(2)
Operating profit for the third quarter and first nine months of 2014 includes AWP litigation charges of $18 million and $68 million, which were recorded in operating expenses.
(3)
Operating profit for the third quarter and first nine months of 2015 includes last-in-first-out (“LIFO”) inventory charges of $95 million and $287 million. Operating profit for the third quarter and first nine months of 2014 includes LIFO inventory charges of $142 million and $186 million. The charges were all recorded in cost of sales.
(4)
Operating profit for the third quarter and first nine months of 2015 includes $51 million and $151 million of acquisition-related expenses, and $16 million and $38 million for the third quarter and first nine months of 2014.
(5)
Operating profit for the first nine months of 2015 includes a charge of $34 million related to the retained workforce business within our International Technology business.
(6)
Operating profit for the third quarter of 2014 includes product alignment charges, integration-related expenses and severance charges totaling $57 million, of which $34 million was recorded in cost of sales and $23 million was recorded in operating expenses. Operating profit for the first nine months of 2014 includes product alignment charges, integration-related expenses and severance charges totaling $60 million, of which $34 million was recorded in cost of sales and $26 million was recorded in operating expenses.
(7)
Corporate expenses, net, for the third quarter and first nine months of 2015 include $1 million and $11 million of acquisition-related expenses and $25 million and $26 million for the third quarter and first nine months of 2014.